Advancing Cross‑Border Clinical Development: HiRO at BIO Korea 2026
HiRO to Attend BIO Korea 2026, April 28–30 in Seoul HiRO is excited to announce…
Article Date
April 20, 2026
This article is featured on another website.
Go to article
March 6, 2026
Labiotech Beyond Biotech podcast with Sean A. MacDonald, CEO of Kainova Therapeutics – Reversing tumor immunosuppression with next-gen GPCR modulation
March 6, 2026
Labiotech Beyond Biotech podcast with Sean A. MacDonald, CEO of Kainova Therapeutics – Reversing tumor immunosuppression with next-gen GPCR modulation
March 26, 2026
pharmaphorum – BIO‑Europe Spring 2026: In conversation with Marjorie Sidhoum, Vice President of Business Development and Corporate Communications at Kainova Therapeutics
March 26, 2026